Wellmune (Beta-1,3/1,6-Glucan, Yeast)

Wellmune is a patented beta-1,3/1,6-glucan derived from baker's yeast (Saccharomyces cerevisiae) that enhances immune function by activating macrophages and natural killer cells. Clinical studies demonstrate it reduces cold incidence by 23% and decreases upper respiratory infection severity.

Origin & History

Wellmune is derived from the cell walls of a proprietary strain of baker's yeast. It undergoes a purification process to isolate the beta-glucan component.

Historical & Cultural Context

Beta-glucans have been used in traditional medicine for centuries, particularly in Asia, for their immune-boosting properties.

Health Benefits

- Enhances immune response by activating key immune cells, reducing the incidence of colds by 23% in clinical trials. - Supports respiratory health by decreasing the severity and duration of upper respiratory tract infections. - Boosts energy levels by modulating immune function, leading to improved vitality and reduced fatigue. - Reduces allergy symptoms by modulating the body's histamine response, providing relief from seasonal allergies. - Improves gut health by supporting the gut barrier function, which enhances nutrient absorption and immune defense. - Decreases inflammation by regulating cytokine production, contributing to overall systemic health. - Promotes skin health by reducing oxidative stress, leading to a more radiant complexion.

How It Works

Wellmune's beta-1,3/1,6-glucan binds to complement receptor 3 (CR3/CD11b/CD18) on immune cells, primarily macrophages and neutrophils. This binding triggers downstream signaling cascades that enhance phagocytosis, cytokine production, and natural killer cell activity. The activated immune cells increase secretion of interleukin-12 and interferon-gamma, strengthening both innate and adaptive immune responses.

Scientific Research

Numerous clinical trials have shown that Wellmune can enhance immune function and reduce the incidence of cold and flu symptoms.

Clinical Summary

Multiple randomized controlled trials have evaluated Wellmune's immune benefits in healthy adults and children. A 12-week study of 162 healthy adults showed 23% reduction in cold incidence and improved quality of life scores. Studies in marathon runners demonstrated reduced upper respiratory tract infection symptoms and faster recovery times. However, most trials have been relatively small (50-200 participants) and industry-sponsored, indicating need for larger independent research.

Nutritional Profile

Wellmune is a purified beta-1,3/1,6-glucan derived from the cell wall of Saccharomyces cerevisiae (baker's yeast). Primary bioactive compound: beta-glucan polysaccharide comprising approximately 75-85% of the ingredient by dry weight, with beta-1,3-glucan forming the main backbone and beta-1,6-glucan side chains responsible for immunomodulatory activity. Typical clinical doses range from 250mg to 500mg per day. Protein content is minimal, approximately 2-5% by weight, consisting of residual yeast cell wall proteins. Carbohydrate content is predominantly the beta-glucan polymer itself; free sugars are negligible (<1%). Fat content is less than 1% by weight. Fiber classification: Wellmune qualifies as a soluble dietary fiber due to its polysaccharide structure, contributing approximately 0.8-1g of fiber per 1g of ingredient. Caloric contribution is minimal, estimated at approximately 1-2 kcal per 250mg serving due to limited digestibility by human enzymes. Micronutrients: trace amounts of phosphorus and magnesium may be present from yeast cell wall residues, but concentrations are nutritionally insignificant. Bioavailability: Wellmune is not absorbed intact; instead, it is phagocytosed by macrophages in Peyer's patches of the gastrointestinal tract, then transported and sequentially broken down into smaller fragments that bind to CR3 receptors on neutrophils and natural killer cells, priming immune response. This receptor-mediated mechanism means bioactivity is high despite lack of systemic absorption. No significant interactions with fat-soluble or water-soluble vitamins have been documented.

Preparation & Dosage

A common dosage is 250 mg per day. Consult a healthcare provider before use.

Synergy & Pairings

Vitamin C, Zinc, Elderberry

Safety & Interactions

Wellmune is generally well-tolerated with minimal reported side effects in clinical studies. Rare mild gastrointestinal symptoms like bloating or nausea may occur in sensitive individuals. No significant drug interactions have been documented, though theoretical concerns exist with immunosuppressive medications due to immune-stimulating effects. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.